Literature DB >> 2499593

The roles of estradiol and progesterone in decreasing luteinizing hormone pulse frequency in the luteal phase of the menstrual cycle.

T B Nippoldt1, N E Reame, R P Kelch, J C Marshall.   

Abstract

During the luteal phase of the menstrual cycle, plasma progesterone (P) and estradiol (E2) concentrations are elevated, and LH (and by inference GnRH) pulse frequency is slow. In contrast, LH pulse frequency increases during the early follicular phase when plasma E2 and P are lower. To examine the mechanism(s) responsible for the slower GnRH pulse frequency in the luteal phase, we maintained plasma P, E2, or both at midluteal concentrations from the midluteal phase to the time of the next early follicular phase and measured the effects on LH secretion. Thirteen normal women with regular menstrual cycles were studied during two or three cycles. Blood was obtained every 10 min during 10-h studies. Control cycle luteal and early follicular studies were followed by a second control study in the luteal phase of the treatment cycle. P (six women), E2 (seven women), or both (five women) then were given twice daily by im injection for 6-12 days until the day corresponding to the early follicular study of the control cycle (EF + P, EF + E2, or EF + E2 + P). A final study was performed 1 week after the injections were discontinued (F). LH pulse frequency was low in the midluteal phase [3.2 +/- 0.2 (+/- SE) pulses/10 h] and increased by the early follicular phase (8.0 +/- 0.8 pulses/10 h) in the control cycles. The increase in LH pulse frequency was not significantly inhibited by administration of P (6.7 +/- 0.7 pulses/10 h; EF + P). However, during both E2 alone and E2 + P, LH pulse frequency remained low (EF + E2, 3.6 +/- 0.8; EF + E2 + P, 2.0 +/- 0.7 pulses/10 h). The mean plasma FSH concentrations paralleled changes in LH pulse frequency, increasing from the luteal to the early follicular phase in the control cycles and during P injections and remaining low during E2 and E2 + P injections. We conclude that continued exposure to P alone does not maintain GnRH pulse frequency at midluteal phase values and that any effect of P requires the presence of E2. As E2 alone maintained lower LH pulse frequency, E2 may act directly to decrease the pulsatile GnRH secretion or it may potentiate the effects of low (less than 3.2 nmol/L) P concentrations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2499593     DOI: 10.1210/jcem-69-1-67

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  15 in total

Review 1.  The role of aromatase inhibitors in ameliorating deleterious effects of ovarian stimulation on outcome of infertility treatment.

Authors:  Mohamed F M Mitwally; Robert F Casper; Michael P Diamond
Journal:  Reprod Biol Endocrinol       Date:  2005-10-04       Impact factor: 5.211

2.  Developmental programming: contribution of prenatal androgen and estrogen to estradiol feedback systems and periovulatory hormonal dynamics in sheep.

Authors:  Almudena Veiga-Lopez; Olga I Astapova; Esther F Aizenberg; James S Lee; Vasantha Padmanabhan
Journal:  Biol Reprod       Date:  2009-01-02       Impact factor: 4.285

3.  Progesterone-Mediated Inhibition of the GnRH Pulse Generator: Differential Sensitivity as a Function of Sleep Status.

Authors:  Su Hee Kim; Jessica A Lundgren; Ruchi Bhabhra; Jessicah S Collins; James T Patrie; Christine M Burt Solorzano; John C Marshall; Christopher R McCartney
Journal:  J Clin Endocrinol Metab       Date:  2018-03-01       Impact factor: 5.958

4.  Persistence of sleep-associated decrease in GnRH pulse frequency in the absence of gonadal steroids.

Authors:  Natalie D Shaw; Sabrina Gill; Helene B Lavoie; Erica E Marsh; Janet E Hall
Journal:  J Clin Endocrinol Metab       Date:  2011-06-06       Impact factor: 5.958

5.  Progesterone treatment inhibits and dihydrotestosterone (DHT) treatment potentiates voltage-gated calcium currents in gonadotropin-releasing hormone (GnRH) neurons.

Authors:  Jianli Sun; Suzanne M Moenter
Journal:  Endocrinology       Date:  2010-08-25       Impact factor: 4.736

Review 6.  Polycystic ovary syndrome in the pediatric population.

Authors:  Andrew A Bremer
Journal:  Metab Syndr Relat Disord       Date:  2010-10       Impact factor: 1.894

Review 7.  Congenital Adrenal Hyperplasia.

Authors:  Selma Feldman Witchel
Journal:  J Pediatr Adolesc Gynecol       Date:  2017-04-24       Impact factor: 1.814

8.  Estradiol and progesterone-induced slowing of gonadotropin-releasing hormone pulse frequency is not reversed by subsequent administration of mifepristone.

Authors:  Christopher R McCartney; Susan K Blank; John C Marshall
Journal:  Endocrine       Date:  2009-07-16       Impact factor: 3.633

9.  Prepubertal Development of GABAergic Transmission to Gonadotropin-Releasing Hormone (GnRH) Neurons and Postsynaptic Response Are Altered by Prenatal Androgenization.

Authors:  Tova Berg; Marina A Silveira; Suzanne M Moenter
Journal:  J Neurosci       Date:  2018-01-26       Impact factor: 6.167

10.  Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder.

Authors:  Shannon D Sullivan; Suzanne M Moenter
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.